Operating Profit mabadiliko
Abbott ABT:US $ 1342M 767M
Abbvie ABBV:US $ 4441M 338M
Acceleron Pharma XLRN:US $ -63.6M 6.01M
Amgen AMGN:US $ 2129M 121M
AstraZeneca AZN:LN 1.13B 768M
Astrazeneca AZN:US 1.13B 768M
Avrobio Inc AVRO:US -26884000 1.18M
Biocryst Pharmaceuticals BCRX:US $ -51.38M 3.04M
Bristol Myers Squibb BMY:US $ 1715M 36M
Eli Lilly And LLY:US $ 1155.3M 836.8M
Enanta Pharmaceuticals ENTA:US $ -29.7M 17.4M
Epizyme EPZM:US $ -64337000 2.19M
GlaxoSmithKline GSK:LN 1.68B 18M
Johnson & Johnson JNJ:US $ 6662M 767M
Karyopharm Therapeutics KPTI:US $ -52373000 15.31M
Macrogenics MGNX:US $ -40279000 11.01M
Merk MRK:US $ 1497M 1517M
Mirati Therapeutics MRTX:US $ -132.42M 26.09M
Nektar Therapeutics NKTR:US $ -109.39M 1.33M
Novartis NOVN:VX 3.48B 1.06B
Novartis NVS:US $ 3479M 1064M
Pfizer PFE:US $ 5914M 397M
Regeneron Pharmaceuticals REGN:US $ 1112.7M 54.3M
Sangamo Biosciences SGMO:US $ -46.3M 2.87M
Tg Therapeutics TGTX:US $ -77.49M 11.71M
Ultragenyx Pharmaceutical RARE:US $ -82.78M 23.79M
Xencor XNCR:US $ -15.67M 1.97M
YTE INCY:US $ 98.8M 65.43M



Karyopharm Therapeutics Faida Ya Uendeshaji - Sasa, maadili, data ya kihistoria, utabiri, takwimu, chati na kalenda ya kiuchumi - Aug 2021.